Researchers at BYU are the first to 3-D print a viable microfluidic device small enough to be effective at a scale much less than 100 micrometers.
Microfluidics, electronics and inkjet technology underlie a newly developed all-in-one biochip that can analyze cells for research and clinical applications.
Biomedical engineering professors have developed an innovative strategy for an integrated microfluidic-based diagnostic device that can perform complex laboratory assays, with such simplicity that these tests can be carried out in the most remote regions of the world. Successfully tested in Rwanda, the mChip diagnoses diseases like HIV and syphilis at patients
